Blood and Tissue Bank

What Blood and Tissue Bank does

Banc de Sang i Teixits (BST), legally "Blood and Tissue Bank," is a public entity wholly owned by the Government of Catalonia's Department of Health, founded in 2000 and headquartered at the Edifici Dr. Frederic Duran i Jordà in Barcelona. It operates a vertically integrated "life bank" model that connects voluntary donors with patients across Catalonia, processing more than 250,000 donations per year and helping over 100,000 recipients annually. The organization runs six core service lines: a blood bank supplying 60+ hospitals and clinics with red cells, platelets, plasma, and therapeutic apheresis services; a multi-tissue bank distributing ocular, musculoskeletal, cardiovascular, and skin allografts; a human milk bank supplying over 600 premature infants per year; the Concordia Program (Barcelona Cord Blood Bank) with 20,000+ stored units and 2,000+ transplants performed in approximately 30 countries; a cellular therapy service with FACT-NetCord, JACIE, and CAT accreditations that includes CAR-T manufacturing (>100 procedures per year) and the IPS-PANIA induced pluripotent stem cell bank (seven clinical-grade lines); and a reference analytical laboratory performing 3 million+ tests annually covering serology, immunohematology, HLA typing, microbiology, genomics, and molecular biology.

The underlying technical stack combines cryopreservation infrastructure (seven bioarchive tanks, seventeen nitrogen tanks, and eleven -80°C freezers), advanced genomic diagnostics (proprietary NGS for HLA/KIR and non-invasive fetal RhD genotyping), and proprietary platforms including the BST Analytics AI engine that predicts donation demand and optimises recruitment, and a Genomics Platform supporting personalised medicine. Certifications (FACT-NetCord, JACIE, CAT, EDQM, AEBT, EATCB) and adherence to ECDC protocols underwrite its regulatory and quality moat.

BST's commercial model is transaction-based against publicly disclosed price lists for blood components, tissues, cord blood, cell therapies, laboratory tests, and biobank samples. Demand is generated through three go-to-market motions that operate concurrently: a community-led donation acquisition funnel (27 daily mobile donation points, schools programs, corporate partnerships, volunteer ambassadors, summer festivals and the "Gold Challenge" plasma campaign); a direct-to-consumer donor experience via bancsang.net and the Àrea Privada del Donant portal for appointment booking and history management; and a sales-led hospital supply operation providing technical direction, hemovigilance, an emergency hotline (607421413), and a private professional ordering portal to 60+ Catalan healthcare facilities. Customer concentration is structural: BST holds a sole mandated role as the technical director for blood services across the Catalan public healthcare system, with reach extended via the Concordia network into six additional Spanish regions and Andorra.

Name

Blood and Tissue Bank

Legal name

Banc de Sang i Teixits

Website

https://bancsang.net

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Blood and Tissue Bank (Banc de Sang i Teixits) is a Catalan public entity providing blood, plasma, tissue, cord blood, breast milk, and advanced cell therapy products and laboratory services to 60+ hospitals and 100,000+ patients annually.

Ownership category

akta.pro rank

Product category

Blood and Tissue Banking Services

NAICS

Blood and Organ Banks (621991), Medical Laboratories (621511), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

akta.pro secondary industries

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

Keywords

• Blood banking services
• Tissue transplantation
• Cord blood banking
• Cellular therapy manufacturing
• Clinical laboratory testing

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Healthcare Service Provision: Supply of blood components, tissues, breast milk, cord blood, and cellular therapies to hospitals and clinics across Catalonia. Technical direction services for over 60 healthcare facilities.
2. Laboratory Testing Services: Comprehensive analytical testing on blood, tissues, breast milk, cells including serology, immunohematology, HLA typing, congenital coagulopathies, microbiology, genomics, and molecular biology for external health centres.
3. Tissue Products: Sale of processed tissues including corneas, musculoskeletal tissues, cardiovascular tissues, skin grafts, and amniotic membrane products to healthcare professionals and implantation centres.
4. Cellular Therapy Services: Processing, cryopreservation, and provision of hematopoietic progenitor cells, lymphocytes, and advanced therapy products. Services include over 100 CAR-T processing per year.
5. Biobank Services: Provision of human biological samples for research and educational purposes to researchers and educators through approved transfer agreements.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels9 records

Core offering

Banc de Sang i Teixits is the integrated blood and tissue bank for Catalonia's public healthcare system, collecting, processing, and supplying blood components (red blood cells, platelets, plasma), tissues (ocular, musculoskeletal, cardiovascular, skin, amniotic membrane), umbilical cord blood, bone marrow, donated human breast milk, and advanced cellular therapy products (including CAR-T). It also operates an analytical laboratory performing over 3 million tests per year and a biobank providing human biological samples for research and educational purposes.

Product overview

The Blood and Tissue Bank (Banc de Sang i Teixits) operates as a comprehensive blood and tissue bank platform serving Catalonia's healthcare system. The organization offers a unified portfolio centered around human-derived substances: Blood Products and Services (covering transfusion services, blood components, therapeutic apheresis, and hemovigilance), the Tissue Bank (providing ocular, musculoskeletal, cardiovascular, and skin tissues), the Breast Milk Bank (collecting and distributing donated human milk to premature infants), the Concordia Cord Blood Program (cryopreserving umbilical cord blood for transplants), and the Cell Therapy Service (preparing cells for hematopoietic stem cell transplantation and advanced therapies). Supporting infrastructure includes a Biobank for research samples, an Analytical Services laboratory conducting over 3 million tests annually, BST Analytics for demand prediction, a Genomics Platform for precision diagnostics, and an Advanced Therapies Platform for gene and cell-based medicines. Healthcare professionals access the platform through Private Area portals for ordering products and managing supply.

Differentiator

Problem solved

Functional benefit

Brands

• Concordia: Inter-regional cooperative program for umbilical cord blood donation involving Catalonia, Balearic Islands, Aragon, Navarre, Extremadura, Cantabria, and Andorra.
• Banc de Llet Materna
• Barcelona Cord Blood Bank
• REDMO
• IPS-PANIA

Products and services

• Blood Products and Services Comprehensive management of the blood process from donation to transfusion, including blood components (red blood cells, platelets, plasma), therapeutic apheresis services, hemovigilance, and transfusion safety services for all hospitals and clinics in Catalonia.
• Tissue Bank Multi-tissue bank providing ocular tissues (corneas, sclera, lamellae), musculoskeletal tissues (bone, cartilage, tendons, meniscal grafts), cardiovascular tissues (heart valves, vascular segments), skin (cryopreserved, glycerolized, dermal matrix), and amniotic membrane products to healthcare professionals and implantation centres.
• Breast Milk Bank (Banc de Llet Materna) Service collecting, analyzing, processing, and distributing donated human breast milk to premature babies who cannot be breastfed by their mothers. Ensures safety and quality through rigorous testing and pasteurization processes. Over 600 premature babies receive breast milk annually.
• Concordia Program (Cord Blood Bank) Inter-territorial cooperative program for umbilical cord blood donation, providing cryopreservation, quality control, storage, and distribution of cord blood units. The program has over 20,000 units stored and has facilitated over 2,000 transplants across approximately 30 countries worldwide. Holds FACT-NetCord and CAT international accreditations.
• Cell Therapy Service Prepares therapeutic cells for hematopoietic stem cell transplantation to treat diseases such as leukemia or lymphoma, other cellular therapies, and manufacturing of advanced therapy medicinal products. Includes cell banks (Cord Blood Bank, REDMO registry, ReDoCel registry, IPS-PANIA iPSC bank), clinical laboratory services, and research with JACIE accreditation.
• Cord Multicomponent Products (CBED and CBPG)

Quantifiable outcome

• Over 100,000 people receive health and well-being assistance annually through donated products
• +4 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature10 records

Partnerships

13 partnerships are on record, tiered minor and core.

• Welsh Blood ServiceminorStrategic or Co-development Partner · 5 August 2025Delegation from Welsh Blood Service visited BST facilities in Barcelona and Zaragoza to explore integrated healthcare models and innovative practices. Observed pioneering 'Life Bank' facility and learned about automation and platelet pooling processes.
• Balearic Islands Health DepartmentcoreStrategic or Co-development PartnerCONCORDIA program partner for umbilical cord blood donation, allowing pregnant women in Balearic Islands to participate in cord blood donation program.
• Aragon Health DepartmentcoreStrategic or Co-development PartnerCONCORDIA program partner for umbilical cord blood donation across Aragon region.
• Navarre Health DepartmentcoreStrategic or Co-development PartnerCONCORDIA program partner for umbilical cord blood donation in Navarre.
• Extremadura Health DepartmentcoreStrategic or Co-development PartnerCONCORDIA program partner for umbilical cord blood donation in Extremadura.
• Cantabria Health DepartmentcoreStrategic or Co-development PartnerCONCORDIA program partner for umbilical cord blood donation in Cantabria.
• Principality of AndorracoreStrategic or Co-development PartnerInternational partner in CONCORDIA program for umbilical cord blood donation, representing cross-border healthcare cooperation.
• Josep Carreras Foundation (REDMO)coreStrategic or Co-development PartnerManaging the Spanish Bone Marrow Donor Registry (REDMO), ensuring cord blood and bone marrow samples collected in Spain can serve any patient worldwide.
• Catalan Health InstitutecoreStrategic or Co-development PartnerCollaboration on own research projects and implementation across Catalan Health Institute centres.
• Public Hospital NetworkcoreStrategic or Co-development PartnerResearch collaborations with many centres across the Public Hospital Network in Catalonia.
• Catalan UniversitiesminorStrategic or Co-development PartnerAcademic partnerships with Catalan Universities for research collaboration and education programs.
• Germans Trias i Pujol Research Institute (IGTP)coreStrategic or Co-development PartnerPartnership on research into extracellular vesicles as revolutionary therapies for the future, leveraging regenerative capacity.
• Hospital del Mar Research InstitutecoreStrategic or Co-development PartnerJoint research and production collaboration to accelerate arrival of treatments to patients.

Scale indicators18 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• NHS Blood and Transplant (NHSBT): UK national public blood and transplant service. Direct peer operating an integrated blood, tissue, and organ donation model under government mandate, matching BST's public entity status and full-service scope including advanced therapies.
• Sanquin Blood Supply Foundation: Dutch national blood bank operating as a not-for-profit foundation. Direct peer with comparable integrated model covering blood collection, processing, diagnostics, and research across the Netherlands.
• Établissement Français du Sang (EFS): French national public blood service. Direct peer with analogous monopoly-style government mandate, integrated blood and tissue banking, and similar scale of donation operations across France.
• Canadian Blood Services: Canadian national blood operator as a charitable not-for-profit. Direct peer with comparable integrated blood, stem cell, and tissue services under a public-mandate model serving a defined population.
• German Red Cross Blood Service (DRK-Blutspendedienst): German regional blood services operated under Red Cross framework. Direct peer covering blood collection, plasma, and stem cell services across Germany with similar public-interest mandate.
• Welsh Blood Service: Welsh national blood service within NHS Wales. Direct peer with smaller-scale but functionally comparable operations; BST has an existing benchmarking relationship with them as referenced in the company data.
• New York Blood Center: Large US non-profit blood center. Direct peer operating integrated blood collection, component processing, and cellular therapy services, with comparable cord blood and advanced therapy programs.
• Centro Nazionale Sangue (Italian National Blood Centre): Italian national blood coordinating authority. Direct peer functioning as a public oversight and coordination body for regional blood services, with comparable public-mandate structure.

Emerging players

• Cord Blood Registry (CBR) by CooperSurgical: Private commercial cord blood banking service. Comparable on the cord blood storage and processing dimension but operates as a paid family-banking model rather than public donation/transplant model like BST's Concordia program.
• Karolinska University Hospital Cell Therapy Lab: Swedish advanced cellular therapy facility within academic medical center. Comparable on the cell therapy, iPSC, and regenerative medicine dimensions where BST is building its IPS-PANIA and CAR-T capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=HFk3jEbpNk0

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blood and Tissue Bank